how long have glp-1 medications been around Chart: 1 in 8 Americans Now Use Drugs for Weight Loss Glucagon-like peptide-1 receptor: mechanisms and

Clinical trial data from the STEP program showed that semaglutide 2.4mg weekly produced average weight loss of 14.9% of body weight over 68 weeks, compared to tirzepatide at 15mg which achieved approximately 22.5% in the SURMOUNT trials

, Fortin, J

Binge Eating Disorder can lead to significant physical and psychological consequences, including obesity, diabetes, depression, and low self-esteem

This is key for your bodys ability to make and maintain lean muscle mass." Joan Salge Blake, RDN, LDN, Boston University The combination of fiber and protein keeps you feeling full longer, which is particularly valuable when your appetite is already reduced by medication

Second, GLP-1 RAs can reduce inflammation in coronary arteries

Verdile G, Keane KN, Cruzat VF, et al